期刊
POSTGRADUATE MEDICAL JOURNAL
卷 84, 期 991, 页码 246-251出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/pgmj.2007.066589
关键词
-
Positron emission tomography ( PET) using F-18-fluorodeoxyglucose (F-18-FDG) has been widely used not only for detecting and staging malignant tumours but also for monitoring therapy response and for differentiating malignant lesions from benign lesions. However, the sensitivity of F-18-FDG PET for hepatocellular carcinoma (HCC) is low. Recent research about the novel drug shows that the sensitivity of C-11-acetate PET for HCC is higher than that of F-18-FDG PET and C-11-acetate also indicates tumour cell differentiation. F-18-FDG PET proved to be highly sensitive in detecting hepatic metastases from different primaries. F-18-FDG PET has also been shown to be useful and more accurate than conventional imaging modalities in demonstrating the effect of local treatments in liver tumours. With the development of small animal imaging, animal research about F-18-FDG PET is increasing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据